Key Insights
The global veterinary vaccines market, projected to reach $12.19 billion by 2025, is anticipated to grow at a CAGR of 7.2% from 2025 to 2033. Key growth drivers include escalating pet ownership, heightened awareness of animal well-being and preventative healthcare, and increased investment in R&D for novel vaccine technologies like mRNA and viral vector platforms. Government mandates for livestock vaccinations to prevent disease outbreaks and protect public health also bolster market expansion. The market is segmented by vaccine type (adjuvants, liposomes, nanoparticles), administration route (oral, intramuscular), and animal type (livestock, companion animals). While livestock vaccination programs dominate current market share, the companion animal segment is experiencing rapid expansion, mirroring the trend in pet ownership.
Veterinary Vaccines Industry Market Size (In Billion)
North America and Europe lead the market due to established veterinary infrastructure and high per capita animal healthcare spending. Emerging economies in Asia-Pacific and Latin America present significant growth opportunities driven by expanding livestock populations and improving veterinary services. Challenges include stringent regulatory approvals and potential vaccine resistance, but the overall market outlook remains positive. Technological advancements, the development of multivalent vaccines, and a growing focus on personalized veterinary medicine are expected to stimulate future market growth. Major players include Zoetis and Merck & Co., Inc., alongside specialized companies, indicating a competitive and innovative market.
Veterinary Vaccines Industry Company Market Share
Veterinary Vaccines Market Analysis: Growth, Trends, and Forecast (2025-2033)
This comprehensive analysis details the veterinary vaccines industry's dynamics, growth trends, regional insights, and key strategies. Covering the base year (2025) and forecast period (2025-2033), this report is an essential resource for industry professionals, investors, and researchers. The market is segmented by type (adjuvants, liposomes, nanoparticles), administration route (oral, intramuscular), and animal type (livestock, companion animal). The total market size is projected to reach 12.19 billion units by 2033.
Veterinary Vaccines Industry Market Dynamics & Structure
The veterinary vaccines market is characterized by a moderately consolidated structure, with key players like Zoetis, Merck & Co Inc, and Phibro Animal Health Corporation holding significant market share. Technological innovation, particularly in adjuvant development and vaccine delivery systems, is a primary growth driver. Stringent regulatory frameworks, varying across different geographies, influence product approvals and market access. Competition from alternative disease management strategies (e.g., antimicrobial treatments) also shapes market dynamics. The increasing prevalence of zoonotic diseases is fueling demand for effective vaccines. Mergers and acquisitions (M&A) activity within the industry is relatively frequent, driven by the desire for portfolio expansion and technological expertise. Recent M&A deal volume is estimated at xx Million units.
- Market Concentration: Moderately consolidated, with top players holding approximately xx% of market share.
- Technological Innovation: Focus on novel adjuvants (e.g., liposomes, nanoparticles), improved delivery systems, and mRNA vaccines.
- Regulatory Landscape: Stringent approvals processes vary across regions, impacting market entry and timelines.
- Competitive Substitutes: Antimicrobial treatments and other disease management strategies pose competitive pressure.
- End-User Demographics: Growing pet ownership and increasing livestock production drive market expansion.
- M&A Trends: Frequent acquisitions and mergers aimed at expanding product portfolios and technological capabilities.
Veterinary Vaccines Industry Growth Trends & Insights
The veterinary vaccines market is experiencing robust growth, driven by factors such as rising pet ownership, increasing livestock populations, heightened awareness of animal health, and government initiatives promoting animal vaccination programs. The market is projected to exhibit a CAGR of xx% during the forecast period (2025-2033), reaching a market size of xx Million units by 2033. This growth is further fueled by advancements in vaccine technology, leading to improved efficacy, safety, and convenience. Consumer preferences are shifting towards multivalent vaccines and novel delivery systems. Technological disruptions, such as the development of mRNA vaccines, are opening new avenues for disease prevention. Market penetration rates for key vaccines are increasing steadily, particularly in emerging economies.
Dominant Regions, Countries, or Segments in Veterinary Vaccines Industry
North America and Europe currently dominate the veterinary vaccines market, driven by high pet ownership rates, stringent animal health regulations, and well-established veterinary infrastructure. However, Asia-Pacific is expected to experience the fastest growth rate due to increasing livestock production and rising disposable incomes. Within the product segments, the demand for vaccines using Alum and Calcium Salts remains significant, but there is growing interest in newer adjuvant technologies like liposomes and nanoparticles for enhanced efficacy. Intramuscular administration is the dominant route, but oral vaccines are gaining traction for ease of administration. The livestock segment holds a larger market share compared to companion animals, but the latter is growing rapidly.
- Key Drivers: High pet ownership (North America, Europe), increasing livestock production (Asia-Pacific), supportive government policies, rising awareness of animal health.
- Dominant Regions: North America and Europe (established markets), Asia-Pacific (high growth potential).
- Leading Segments: Alum and Calcium Salts (largest segment), Intramuscular route (dominant administration), Livestock (largest animal type).
Veterinary Vaccines Industry Product Landscape
The veterinary vaccines market offers a diverse range of products tailored to specific animal species and diseases. Recent innovations include multivalent vaccines offering broader protection against multiple pathogens, and vaccines employing novel adjuvants to enhance immune responses. There's a growing focus on improving vaccine stability, reducing side effects, and developing user-friendly administration methods. Companies are investing heavily in research and development to address emerging diseases and improve the efficacy of existing vaccines.
Key Drivers, Barriers & Challenges in Veterinary Vaccines Industry
Key Drivers: Rising pet ownership globally, increasing livestock production, growing awareness of zoonotic diseases, government initiatives supporting animal vaccination.
Key Challenges: Stringent regulatory hurdles for new vaccine approvals, high research and development costs, competition from alternative therapies, maintaining cold chain integrity for vaccine distribution, and ensuring vaccine safety and efficacy. The impact of these challenges can result in market entry delays and increased production costs, potentially limiting market growth by xx% by 2030.
Emerging Opportunities in Veterinary Vaccines Industry
Emerging opportunities lie in the development of vaccines targeting emerging infectious diseases, personalized vaccines tailored to specific animal populations, and innovative vaccine delivery systems. There is significant potential in untapped markets in developing economies and expanding into new animal species. The growing interest in companion animal health and the increasing demand for convenient, user-friendly vaccines present further opportunities.
Growth Accelerators in the Veterinary Vaccines Industry
Technological advancements in vaccine development, strategic partnerships between pharmaceutical companies and veterinary clinics, expansion into new geographical markets, and increasing collaborations between research institutions and industry players are key growth catalysts. The development of novel adjuvants and delivery systems will drive further innovation and market expansion.
Key Players Shaping the Veterinary Vaccines Industry Market
- SPI Pharma
- Merck & Co Inc
- Zoetis
- OZ Biosciences
- Croda International PLC
- SEPPIC
- Invivogen
- Phibro Animal Health Corporation
- Bioveta AS
Notable Milestones in Veterinary Vaccines Industry Sector
- December 2022: Evonik launched PhytoSquene, a non-animal-derived squalene for use in vaccine adjuvants. This significantly reduces reliance on animal-sourced components and improves sustainability.
- June 2022: ICAR-NRC launched animal vaccines containing inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant, expanding the range of available vaccines for various animal species.
In-Depth Veterinary Vaccines Industry Market Outlook
The veterinary vaccines market is poised for continued growth, driven by technological advancements, expanding market reach, and increasing awareness of animal health. Strategic partnerships and investments in research and development will play a crucial role in shaping the future of this industry. The market’s potential lies in developing innovative products that address unmet needs, improve disease prevention, and enhance animal welfare. The focus on personalized medicine and precision vaccination approaches holds immense promise for future expansion.
Veterinary Vaccines Industry Segmentation
-
1. Type
- 1.1. Alum and Calcium Salts
- 1.2. Oil Emulsion Adjuvants
- 1.3. Liposomes and Archaeosomes
- 1.4. Nanoparticles and Microparticles
- 1.5. Other Types
-
2. Route of Administration
- 2.1. Oral
- 2.2. Intramuscular
- 2.3. Other Routes of Administration
-
3. Animal Type
- 3.1. Livestock
- 3.2. Companion Animal
Veterinary Vaccines Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
Veterinary Vaccines Industry Regional Market Share
Geographic Coverage of Veterinary Vaccines Industry
Veterinary Vaccines Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.2% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Use of Adjuvants in Vaccines; Increasing Livestock Population and Associated Diseases; High Incidence of Diseases
- 3.3. Market Restrains
- 3.3.1. High Toxicity and Side Effects of Adjuvants
- 3.4. Market Trends
- 3.4.1. Companion Animal Segment is Expected to Witness Considerable Growth During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Alum and Calcium Salts
- 5.1.2. Oil Emulsion Adjuvants
- 5.1.3. Liposomes and Archaeosomes
- 5.1.4. Nanoparticles and Microparticles
- 5.1.5. Other Types
- 5.2. Market Analysis, Insights and Forecast - by Route of Administration
- 5.2.1. Oral
- 5.2.2. Intramuscular
- 5.2.3. Other Routes of Administration
- 5.3. Market Analysis, Insights and Forecast - by Animal Type
- 5.3.1. Livestock
- 5.3.2. Companion Animal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. North America Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Type
- 6.1.1. Alum and Calcium Salts
- 6.1.2. Oil Emulsion Adjuvants
- 6.1.3. Liposomes and Archaeosomes
- 6.1.4. Nanoparticles and Microparticles
- 6.1.5. Other Types
- 6.2. Market Analysis, Insights and Forecast - by Route of Administration
- 6.2.1. Oral
- 6.2.2. Intramuscular
- 6.2.3. Other Routes of Administration
- 6.3. Market Analysis, Insights and Forecast - by Animal Type
- 6.3.1. Livestock
- 6.3.2. Companion Animal
- 6.1. Market Analysis, Insights and Forecast - by Type
- 7. Europe Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Type
- 7.1.1. Alum and Calcium Salts
- 7.1.2. Oil Emulsion Adjuvants
- 7.1.3. Liposomes and Archaeosomes
- 7.1.4. Nanoparticles and Microparticles
- 7.1.5. Other Types
- 7.2. Market Analysis, Insights and Forecast - by Route of Administration
- 7.2.1. Oral
- 7.2.2. Intramuscular
- 7.2.3. Other Routes of Administration
- 7.3. Market Analysis, Insights and Forecast - by Animal Type
- 7.3.1. Livestock
- 7.3.2. Companion Animal
- 7.1. Market Analysis, Insights and Forecast - by Type
- 8. Asia Pacific Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Type
- 8.1.1. Alum and Calcium Salts
- 8.1.2. Oil Emulsion Adjuvants
- 8.1.3. Liposomes and Archaeosomes
- 8.1.4. Nanoparticles and Microparticles
- 8.1.5. Other Types
- 8.2. Market Analysis, Insights and Forecast - by Route of Administration
- 8.2.1. Oral
- 8.2.2. Intramuscular
- 8.2.3. Other Routes of Administration
- 8.3. Market Analysis, Insights and Forecast - by Animal Type
- 8.3.1. Livestock
- 8.3.2. Companion Animal
- 8.1. Market Analysis, Insights and Forecast - by Type
- 9. Middle East and Africa Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Type
- 9.1.1. Alum and Calcium Salts
- 9.1.2. Oil Emulsion Adjuvants
- 9.1.3. Liposomes and Archaeosomes
- 9.1.4. Nanoparticles and Microparticles
- 9.1.5. Other Types
- 9.2. Market Analysis, Insights and Forecast - by Route of Administration
- 9.2.1. Oral
- 9.2.2. Intramuscular
- 9.2.3. Other Routes of Administration
- 9.3. Market Analysis, Insights and Forecast - by Animal Type
- 9.3.1. Livestock
- 9.3.2. Companion Animal
- 9.1. Market Analysis, Insights and Forecast - by Type
- 10. South America Veterinary Vaccines Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Type
- 10.1.1. Alum and Calcium Salts
- 10.1.2. Oil Emulsion Adjuvants
- 10.1.3. Liposomes and Archaeosomes
- 10.1.4. Nanoparticles and Microparticles
- 10.1.5. Other Types
- 10.2. Market Analysis, Insights and Forecast - by Route of Administration
- 10.2.1. Oral
- 10.2.2. Intramuscular
- 10.2.3. Other Routes of Administration
- 10.3. Market Analysis, Insights and Forecast - by Animal Type
- 10.3.1. Livestock
- 10.3.2. Companion Animal
- 10.1. Market Analysis, Insights and Forecast - by Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 SPI Pharma
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Merck & Co Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Zoetis
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 OZ Biosciences*List Not Exhaustive
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Croda International PLC
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 SEPPIC
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Invivogen
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Phibro Animal Health Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Bioveta AS
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.1 SPI Pharma
List of Figures
- Figure 1: Global Veterinary Vaccines Industry Revenue Breakdown (billion, %) by Region 2025 & 2033
- Figure 2: North America Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 3: North America Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 4: North America Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 5: North America Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 6: North America Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 7: North America Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 8: North America Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 9: North America Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: Europe Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 11: Europe Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 12: Europe Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 13: Europe Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 14: Europe Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 15: Europe Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 16: Europe Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 17: Europe Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 19: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 20: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 21: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 22: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 23: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 24: Asia Pacific Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 25: Asia Pacific Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 27: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 28: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 29: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 30: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 31: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 32: Middle East and Africa Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 33: Middle East and Africa Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: South America Veterinary Vaccines Industry Revenue (billion), by Type 2025 & 2033
- Figure 35: South America Veterinary Vaccines Industry Revenue Share (%), by Type 2025 & 2033
- Figure 36: South America Veterinary Vaccines Industry Revenue (billion), by Route of Administration 2025 & 2033
- Figure 37: South America Veterinary Vaccines Industry Revenue Share (%), by Route of Administration 2025 & 2033
- Figure 38: South America Veterinary Vaccines Industry Revenue (billion), by Animal Type 2025 & 2033
- Figure 39: South America Veterinary Vaccines Industry Revenue Share (%), by Animal Type 2025 & 2033
- Figure 40: South America Veterinary Vaccines Industry Revenue (billion), by Country 2025 & 2033
- Figure 41: South America Veterinary Vaccines Industry Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 2: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 3: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 4: Global Veterinary Vaccines Industry Revenue billion Forecast, by Region 2020 & 2033
- Table 5: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 6: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 7: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 8: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 9: United States Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 10: Canada Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 11: Mexico Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 12: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 13: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 14: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 15: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 16: Germany Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 17: United Kingdom Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 18: France Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 19: Italy Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 20: Spain Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 21: Rest of Europe Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 22: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 23: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 24: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 25: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 26: China Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 27: Japan Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 28: India Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 29: Australia Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 30: South Korea Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 31: Rest of Asia Pacific Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 32: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 33: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 34: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 35: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 36: GCC Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 37: South Africa Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 38: Rest of Middle East and Africa Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 39: Global Veterinary Vaccines Industry Revenue billion Forecast, by Type 2020 & 2033
- Table 40: Global Veterinary Vaccines Industry Revenue billion Forecast, by Route of Administration 2020 & 2033
- Table 41: Global Veterinary Vaccines Industry Revenue billion Forecast, by Animal Type 2020 & 2033
- Table 42: Global Veterinary Vaccines Industry Revenue billion Forecast, by Country 2020 & 2033
- Table 43: Brazil Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 44: Argentina Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
- Table 45: Rest of South America Veterinary Vaccines Industry Revenue (billion) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Veterinary Vaccines Industry?
The projected CAGR is approximately 7.2%.
2. Which companies are prominent players in the Veterinary Vaccines Industry?
Key companies in the market include SPI Pharma, Merck & Co Inc, Zoetis, OZ Biosciences*List Not Exhaustive, Croda International PLC, SEPPIC, Invivogen, Phibro Animal Health Corporation, Bioveta AS.
3. What are the main segments of the Veterinary Vaccines Industry?
The market segments include Type, Route of Administration, Animal Type.
4. Can you provide details about the market size?
The market size is estimated to be USD 12.19 billion as of 2022.
5. What are some drivers contributing to market growth?
Rising Use of Adjuvants in Vaccines; Increasing Livestock Population and Associated Diseases; High Incidence of Diseases.
6. What are the notable trends driving market growth?
Companion Animal Segment is Expected to Witness Considerable Growth During the Forecast Period.
7. Are there any restraints impacting market growth?
High Toxicity and Side Effects of Adjuvants.
8. Can you provide examples of recent developments in the market?
In December 2022, Evonik launched non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene is the first known amaranth oil-derived squalene for use in adjuvants in parenteral dosage forms.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Veterinary Vaccines Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Veterinary Vaccines Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Veterinary Vaccines Industry?
To stay informed about further developments, trends, and reports in the Veterinary Vaccines Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence